Inhibition of gentamicin-induced renal tubular cell necrosis

Majid Tavafi1

  • 1Department of Anatomy, Faculty of Medicine, Lorestan University of Medical Sciences, Khoram Abad Iran.

Insights

Erythropoietin effectively protects against gentamicin nephrotoxicity, improving kidney function and reducing tubular damage. This suggests erythropoietin as a potential therapeutic agent for gentamicin-induced kidney injury.

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Gentamicin, an antibiotic for gram-negative infections, causes nephrotoxicity, limiting its use.
  • Oxidative stress is a key mechanism in gentamicin-induced kidney damage.
  • Antioxidant agents have shown promise in mitigating gentamicin nephrotoxicity.

Purpose of the Study:

  • To investigate the renoprotective effects of erythropoietin against gentamicin-induced nephrotoxicity in rats.
  • To evaluate erythropoietin's efficacy when administered simultaneously with or after gentamicin exposure.
  • To assess the impact of erythropoietin on biochemical markers and kidney histology.

Main Methods:

  • Rats were induced with gentamicin nephrotoxicity.
  • Erythropoietin was administered either concurrently with gentamicin or after nephrotoxicity induction for 10 days.
  • Serum creatinine and blood urea nitrogen levels were measured.
  • Kidney tissues were examined for histopathological changes, particularly tubular necrosis.

Main Results:

  • Erythropoietin significantly improved serum creatinine and blood urea nitrogen levels in gentamicin-treated rats.
  • Simultaneous and post-induction erythropoietin treatment demonstrated significant renoprotective effects.
  • Erythropoietin ameliorated gentamicin-induced histopathological injuries, including tubular cell necrosis.

Conclusions:

  • Erythropoietin demonstrates significant renoprotective effects against gentamicin-induced nephrotoxicity.
  • The study highlights erythropoietin's potential as a therapeutic strategy for mitigating kidney damage caused by gentamicin.
  • While mechanisms require further elucidation, histological and biochemical outcomes are promising.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
386
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.4K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
335
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
191